Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Annals of Translational Medicine|November 18, 2021
Survival rates of patients with tumors originating in different segments of the left upper lung in stage I to III non-small cell lung cancerYi Xiao, Shaoning Luo, Jinyuan He, et al.International Journal of Surgery (London, England)|February 18, 2026
Explore the potential mechanisms between ertugliflozin and kidney cancer through bioinformatics analysis and Mendelian randomization studyBo Xu, Peng Xiang, Xiongwen Yang, et al.Frontiers in Public Health|October 28, 2022
Association of high PM<sub>2.5</sub> levels with short-term and medium-term lung function recovery in patients with pulmonary lobectomyYi-Tong Liu, Yi Xiao, Jian Huang, et al.Nursing Ethics|May 27, 2026
When machines explain medicine: Nursing ethics and clinical communicationXiongwen Yang, Yuanwei Liang, Yijiang Liu, et al.Frontiers in Oncology|March 3, 2022
Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective StudyYi Xiao, Jinyuan He, Shaoning Luo, et al.Therapeutic Advances in Medical Oncology|December 19, 2025
Prediction of immunotherapy efficacy for pulmonary lymphoepithelioma-like carcinoma using baseline routine blood tests and serum tumor markers: a multicenter retrospective studyXiongwen Yang, Yuanwei Liang, Hao Hu, et al.Therapeutic Advances in Medical Oncology|February 3, 2025
Efficacy and safety of immunotherapy in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma: a multicenter retrospective studyXiongwen Yang, Yi Xiao, Yubin Zhou, et al.Therapeutic Advances in Medical Oncology|November 3, 2023
Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective studyXiongwen Yang, Yi Xiao, Yubin Zhou, et al.Annals of Surgical Oncology|September 1, 2023
Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in ChinaXiongwen Yang, Yi Xiao, Hao Hu, et al.Journal of Cancer Research and Therapeutics|September 7, 2023
Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter studyYuBin Zhou, Jian Huang, Jun Lan, et al.Pageof 3